First Time Loading...

Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.54 USD 3.86% Market Closed
Updated: May 4, 2024

Accolade Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Accolade Inc
Cost of Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Accolade Inc
NASDAQ:ACCD
Cost of Revenue
-$198.9m
CAGR 3-Years
-39%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cost of Revenue
-$8.3B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Cost of Revenue
-$6.2B
CAGR 3-Years
0%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
CVS Health Corp
NYSE:CVS
Cost of Revenue
-$307.3B
CAGR 3-Years
-23%
CAGR 5-Years
-15%
CAGR 10-Years
-11%
Cigna Corp
NYSE:CI
Cost of Revenue
-$170.1B
CAGR 3-Years
-8%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cost of Revenue
-$8.9B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
-9%

See Also

What is Accolade Inc's Cost of Revenue?
Cost of Revenue
-198.9m USD

Based on the financial report for Feb 28, 2023, Accolade Inc's Cost of Revenue amounts to -198.9m USD.

What is Accolade Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-30%

Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for Accolade Inc have been -39% over the past three years , -30% over the past five years .